The microbiome-gut-brain axis: implications for schizophrenia and antipsychotic induced weight gain

‘Small Changes' to Diet and Physical Activity Behaviors for Weight Management

Hills, A. P., Byrne, N. M., Lindstrom, R. C., & Hill, J. O. (2013) · Obesity Facts · doi:10.1159/000345030 · Cited by 9,526 · see citing works

A core gut microbiome in obese and lean twins

Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823 · see citing works

The gut microbiota as an environmental factor that regulates fat storage

Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245 · see citing works

TLR4 links innate immunity and fatty acid-induced insulin resistance

Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H., & Flier, J. S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28898 · Cited by 3,690 · see citing works

Microbiota Modulate Behavioral and Physiological Abnormalities Associated with Neurodevelopmental Disorders

Hsiao, E. Y., McBride, S. W., Hsien, S., Sharon, G., Hyde, E. R., McCue, T., Codelli, J. A., Chow, J., Reisman, S. E., Petrosino, J. F., et al. (2013) · Cell · doi:10.1016/j.cell.2013.11.024 · Cited by 3,283 · see citing works

Postnatal microbial colonization programs the hypothalamic–pituitary–adrenal system for stress response in mice

Sudo, N., Chida, Y., Aiba, Y., Sonoda, J., Oyama, N., Yu, X., Kubo, C., & Koga, Y. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.063388 · Cited by 2,735 · see citing works

Altered fecal microbiota composition in patients with major depressive disorder

Jiang, H., Ling, Z., Zhang, Y., Mao, H., Ma, Z., Yin, Y., Wang, W., Tang, W., Tan, Z., Shi, J., et al. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.03.016 · Cited by 2,275 · see citing works

Regulation of short-chain fatty acid production

Macfarlane, S., & Macfarlane, G. T. (2003) · Proceedings of the Nutrition Society · doi:10.1079/pns2002207 · Cited by 1,939 · see citing works

The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner

Clarke, G., Grenham, S., Scully, P., Fitzgerald, P., Moloney, R. D., Shanahan, F., Dinan, T. G., & Cryan, J. F. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.77 · Cited by 1,893 · see citing works

The Intestinal Microbiota Affect Central Levels of Brain-Derived Neurotropic Factor and Behavior in Mice

Bercik, P., Denou, E., Collins, J., Jackson, W., Lu, J., Jury, J., Deng, Y., Blennerhassett, P., Macri, J., McCoy, K. D., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.04.052 · Cited by 1,748 · see citing works

Consumption of fermented milk product with probiotic modulates brain activity

Tillisch, K., Labus, J., Kilpatrick, L., Jiang, Z., Stains, J., Ebrat, B., Guyonnet, D., Legrain–Raspaud, S., Trotin, B., Naliboff, B., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.02.043 · Cited by 1,192 · see citing works

High Fat Diet-Induced Gut Microbiota Exacerbates Inflammation and Obesity in Mice via the TLR4 Signaling Pathway

Kim, K., Gu, W., Lee, I., Joh, E., & Kim, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047713 · Cited by 1,184 · see citing works

Exposure to a social stressor alters the structure of the intestinal microbiota: Implications for stressor-induced immunomodulation

Bailey, M. T., Dowd, S. E., Galley, J. D., Hufnagle, A. R., Allen, R. G., & Lyte, M. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.10.023 · Cited by 1,123 · see citing works

Correlation between the human fecal microbiota and depression

Naseribafrouei, A., Hestad, K., Avershina, E., Sekelja, M., Linløkken, A., Wilson, R., & Rudi, K. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12378 · Cited by 1,044 · see citing works

Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression

Desbonnet, L., Garrett, L., Clarke, G., Kiely, B., Cryan, J. F., & Dinan, T. G. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.08.005 · Cited by 999 · see citing works

From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways

Rogers, G. B., Keating, D. J., Young, R. L., Wong, M.-L., Licinio, J., & Wesselingh, S. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.50 · Cited by 969 · see citing works

The probiotic Bifidobacteria infantis: an assessment of potential antidepressant properties in the rat

Desbonnet, L., Garrett, L., Clarke, G., Bienenstock, J., & Dinan, T. G. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.03.009 · Cited by 952 · see citing works

Bacterial infection causes stress-induced memory dysfunction in mice

Gareau, M. G., Wine, E., Rodrigues, D. M., Cho, J. H., Whary, M. T., Philpott, D. J., MacQueen, G., & Sherman, P. M. (2011) · Gut · doi:10.1136/gut.2009.202515 · Cited by 909 · cited 1× · see citing works

Gut microbiota depletion from early adolescence in mice: implications for brain and behaviour

Desbonnet, L., Clarke, G., Traplin, A., O’Sullivan, O., Crispie, F., Moloney, R. D., Cotter, P. D., Dinan, T. G., & Cryan, J. F. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.04.004 · Cited by 760 · see citing works

Comparison of the gut microbiota composition between obese and non-obese individuals in a Japanese population, as analyzed by terminal restriction fragment length polymorphism and next-generation sequencing

Kasai, C., Sugimoto, K., Moritani, I., Tanaka, J., Oya, Y., Inoue, H., Tameda, M., Shiraki, K., Ito, M., Takei, Y., et al. (2015) · BMC Gastroenterology · doi:10.1186/s12876-015-0330-2 · Cited by 581 · see citing works

Beneficial psychological effects of a probiotic formulation ( <i>Lactobacillus helveticus</i> R0052 and <i>Bifidobacterium longum</i> R0175) in healthy human volunteers

Messaoudi, M., Violle, N., Bisson, J.-F., Desor, D., Javelot, H., & Rougeot, C. (2011) · Gut Microbes · doi:10.4161/gmic.2.4.16108 · Cited by 574 · see citing works

The microbiome: a key regulator of stress and neuroinflammation

Rea, K., Dinan, T. G., & Cryan, J. F. (2016) · Neurobiology of Stress · doi:10.1016/j.ynstr.2016.03.001 · Cited by 508 · see citing works

A systematic review of environmental factors and obesogenic dietary intakes among adults: are we getting closer to understanding obesogenic environments?

Giskes, K., van Lenthe, F. J., Avendano‐Pabon, M., & Brug, J. (2010) · Obesity Reviews · doi:10.1111/j.1467-789x.2010.00769.x · Cited by 479 · see citing works

Phagocyte-derived catecholamines enhance acute inflammatory injury

Flierl, M. A., Rittirsch, D., Nadeau, B. A., Chen, A. J., Sarma, J. V., Zetoune, F. S., McGuire, S. R., List, R. P., Day, D. E., Hoesel, L. M., et al. (2007) · Nature · doi:10.1038/nature06185 · Cited by 475 · see citing works

Schizophrenia-Relevant Behavioral Testing in Rodent Models: A Uniquely Human Disorder?

Powell, C. M., & Miyakawa, T. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.05.008 · Cited by 368 · see citing works

Brain–gut–microbiota axis — mood, metabolism and behaviour

Dinan, T. G., & Cryan, J. F. (2017) · Nature Reviews Gastroenterology &amp; Hepatology · doi:10.1038/nrgastro.2016.200 · Cited by 361 · see citing works

The gut microbiome and obesity

John, G. K., & Mullin, G. E. (2016) · Current Oncology Reports · doi:10.1007/s11912-016-0528-7 · Cited by 304 · see citing works

Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters

Davey, K. J., O’Mahony, S. M., Schellekens, H., O’Sullivan, O., Bienenstock, J., Cotter, P. D., Dinan, T. G., & Cryan, J. F. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2555-2 · Cited by 275 · see citing works

Composition, taxonomy and functional diversity of the oropharynx microbiome in individuals with schizophrenia and controls

Castro‐Nallar, E., Bendall, M. L., Pérez‐Losada, M., Sabunciyan, S., Severance, E. G., Dickerson, F., Schroeder, J. R., Yolken, R. H., & Crandall, K. A. (2015) · PeerJ · doi:10.7717/peerj.1140 · Cited by 269 · see citing works

Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications

Lett, T. A. P., Wallace, T., Chowdhury, N. I., Tiwari, A. K., Kennedy, J. L., & Müller, D. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.109 · Cited by 264 · see citing works

Microbes, immunity, and behavior: psychoneuroimmunology meets the microbiome

Dinan, T. G., & Cryan, J. F. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.103 · Cited by 246 · see citing works

Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia

Severance, E. G., Gressitt, K. L., Stallings, C. R., Origoni, A. E., Khushalani, S., Leweke, F. M., Dickerson, F. B., & Yolken, R. H. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.05.018 · Cited by 243 · see citing works

Acute Effects of Atypical Antipsychotics on Whole-Body Insulin Resistance in Rats: Implications for Adverse Metabolic Effects

Houseknecht, K. L., Robertson, A. S., Zavadoski, W. J., Gibbs, E. M., Johnson, D. E., & Rollema, H. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301209 · Cited by 239 · see citing works

Antipsychotics and the gut microbiome: olanzapine-induced metabolic dysfunction is attenuated by antibiotic administration in the rat

Davey, K. J., Cotter, P. D., O'Sullivan, O., Crispie, F., Dinan, T. G., Cryan, J. F., & O'Mahony, S. M. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.83 · Cited by 236 · see citing works

Effect of Probiotics on Glycemic Control: A Systematic Review and Meta-Analysis of Randomized, Controlled Trials

Ruan, Y., Sun, J. M., He, J., Chen, F., Chen, R., & Chen, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132121 · Cited by 214 · see citing works

“First do no harm.” A systematic review of the prevalence and management of antipsychotic adverse effects

Young, S. L., Taylor, M., & Lawrie, S. M. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114562090 · Cited by 212 · see citing works

The antipsychotic olanzapine interacts with the gut microbiome to cause weight gain in mouse

Morgan, A. P., Crowley, J. J., Nonneman, R. J., Quackenbush, C. R., Miller, C. N., Ryan, A. K., Bogue, M. A., Paredes, S. H., Yourstone, S., Carroll, I. M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115225 · Cited by 197 · see citing works

Use of the second-generation antipsychotic, risperidone, and secondary weight gain are associated with an altered gut microbiota in children

Bahr, S. M., Tyler, B. C., Wooldridge, N., Butcher, B. D., Burns, T. L., Teesch, L. M., Oltman, C. L., Azcarate-Peril, M. A., Kirby, J. R., & Calarge, C. A. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.135 · Cited by 197 · see citing works

Gut microbiome composition is associated with temperament during early childhood

Christian, L. M., Galley, J. D., Hade, E. M., Schoppe-Sullivan, S., Kamp Dush, C., & Bailey, M. T. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.10.018 · Cited by 191 · see citing works

Effect of Probiotic Supplementation on Schizophrenia Symptoms and Association With Gastrointestinal Functioning: A Randomized, Placebo-Controlled Trial

Dickerson, F. B., Stallings, C., Origoni, A., Katsafanas, E., Savage, C. L. G., Schweinfurth, L. A. B., Goga, J., Khushalani, S., & Yolken, R. H. (2014) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.13m01579 · Cited by 166 · see citing works

Potential mechanisms of atypical antipsychotic-induced metabolic derangement: Clues for understanding obesity and novel drug design

Coccurello, R., & Moles, A. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.04.008 · Cited by 146 · see citing works

Risperidone-induced weight gain is mediated through shifts in the gut microbiome and suppression of energy expenditure

Bahr, S. M., Weidemann, B. J., Castro, A. N., Walsh, J. W., deLeon, O., Burnett, C. M. L., Pearson, N. A., Murry, D. J., Grobe, J. L., & Kirby, J. R. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.10.018 · Cited by 143 · see citing works

Insulin resistance and secretion in vivo: Effects of different antipsychotics in an animal model

Chintoh, A. F., Mann, S. W., Lam, L., Giacca, A., Fletcher, P. J., Nóbrega, J. N., & Remington, G. J. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2008.12.012 · Cited by 117 · see citing works

Increased IgA responses to the LPS of commensal bacteria is associated with inflammation and activation of cell-mediated immunity in chronic fatigue syndrome

Maes, M. H. J., Twisk, F., Kubera, M., Ringel, K., Leunis, J., & Geffard, M. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.09.010 · Cited by 108 · see citing works

The possible mechanisms of the human microbiome in allergic diseases

İpçi, K., Altıntoprak, N., Muluk, N. B., Şentürk, M., & Cingi, C. (2016) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-016-4058-6 · Cited by 106 · see citing works

Pharmacogenetics of Antipsychotics

Brandl, E. J., Kennedy, J. L., & Müller, D. J. (2014) · The Canadian Journal of Psychiatry · doi:10.1177/070674371405900203 · Cited by 100 · see citing works

Antipsychotics-induced metabolic alterations: Focus on adipose tissue and molecular mechanisms

Gonçalves, P., Araújo, J. R., & Martel, F. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.11.008 · Cited by 97 · see citing works

Effects of Olanzapine and Haloperidol on the Metabolic Status of Healthy Men

Vidarsdóttir, S., van Weenen, J. E. D. L., Frölich, M., Roelfsema, F., Romijn, J. A., & Pijl, H. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1815 · Cited by 91 · see citing works

Acute Effects of Single-Dose Olanzapine on Metabolic, Endocrine, and Inflammatory Markers in Healthy Controls

Hahn, M., Wolever, T., Arenovich, T., Teo, C., Giacca, A., Powell, V., Clarke, L., Fletcher, P. J., Cohn, T. A., McIntyre, R. S., et al. (2013) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31829e8333 · Cited by 83 · see citing works

Inflammation and schizophrenia

Al-Asmari, A., & Khan, M. W. (2013) · Human & Experimental Toxicology · doi:10.1177/0960327113493305 · Cited by 55 · see citing works

The gastrointestinal microbiome – Functional interference between stomach and intestine

Lopetuso, L. R., Scaldaferri, F., Franceschi, F., & Gasbarrini, A. (2014) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2014.10.004 · Cited by 50 · see citing works

Metabolic and inflammatory genes in schizophrenia

Chase, K. A., Rosen, C., Gin, H., Bjorkquist, O. A., Feiner, B., Marvin, R. W., Conrin, S. D., & Sharma, R. P. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.11.007 · Cited by 45 · see citing works

Atypical antipsychotics and effects on feeding: from mice to men

Benarroch, L., Kowalchuk, C., Wilson, V. S., Teo, C., Guenette, M. D., Chintoh, A. F., Nesarajah, Y., Taylor, V. H., Selby, P. L., Fletcher, P. J., et al. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4324-8 · Cited by 39 · see citing works

Alzheimer’s disease and gut microbiota modifications: The long way between preclinical studies and clinical evidence

Mancuso, C., & Santangelo, R. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2017.12.009 · Cited by 232 · see citing works

Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in Schizophrenia

MacKenzie, N. E., Kowalchuk, C., Agarwal, S. M., Costa-Dookhan, K. A., Caravaggio, F., Gerretsen, P., Chintoh, A. F., Remington, G. J., Taylor, V. H., Müller, D. J., et al. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00622 · Cited by 206 · see citing works

Leaky brain in neurological and psychiatric disorders: Drivers and consequences

Morris, G., Fernandes, B. S., Puri, B. K., Walker, A. J., Carvalho, A. F., & Berk, M. (2018) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867418796955 · Cited by 144 · see citing works

Diet and Psychosis: A Scoping Review

Aucoin, M., LaChance, L., Cooley, K., & Kidd, S. A. (2018) · Neuropsychobiology · doi:10.1159/000493399 · Cited by 114 · see citing works

The Complex Relationship between Antipsychotic-Induced Weight Gain and Therapeutic Benefits: A Systematic Review and Implications for Treatment

Raben, A., Marshe, V. S., Chintoh, A. F., Gorbovskaya, I., Müller, D. J., & Hahn, M. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00741 · Cited by 114 · see citing works

Autonomic nervous system dysfunction in schizophrenia: impact on cognitive and metabolic health

Stogios, N., Gdanski, A., Gerretsen, P., Chintoh, A. F., Graff-Guerrero, A., Rajji, T. K., Remington, G., Hahn, M. K., & Agarwal, S. M. (2021) · npj Schizophrenia · doi:10.1038/s41537-021-00151-6 · Cited by 98 · see citing works

Second-generation antipsychotics and metabolism alterations: a systematic review of the role of the gut microbiome

Skonieczna‐Żydecka, K., Łoniewski, I., Misera, A., Stachowska, E., Maciejewska, D., Marlicz, W. M., & Galling, B. (2018) · Psychopharmacology · doi:10.1007/s00213-018-5102-6 · Cited by 101 · see citing works

Systematically investigating the impact of medication on the gut microbiome

Maier, L., & Typas, A. (2017) · Current Opinion in Microbiology · doi:10.1016/j.mib.2017.11.001 · Cited by 90 · see citing works

Antipsychotics-induced metabolic alterations: Recounting the mechanistic insights, therapeutic targets and pharmacological alternatives

Singh, R., Bansal, Y., Medhi, B., & Kuhad, A. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.12.003 · Cited by 90 · see citing works

Interleukin-6 in Schizophrenia—Is There a Therapeutic Relevance?

Borovčanin, M., Jovanović, I., Radosavljevic, G. D., Pantic, J. M., Janicijevic, S. M., Arsenijević, N., & Lukić, M. L. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00221 · Cited by 91 · see citing works

Possible links between gut–microbiota and attention-deficit/hyperactivity disorders in children and adolescents

Boonchooduang, N., Louthrenoo, O., Chattipakorn, N., & Chattipakorn, S. C. (2020) · European Journal of Nutrition · doi:10.1007/s00394-020-02383-1 · Cited by 76 · see citing works

Nrf2/ARE Activators Improve Memory in Aged Mice via Maintaining of Mitochondrial Quality Control of Brain and the Modulation of Gut Microbiome

Sadovnikova, I. S., Gureev, A. P., Ignatyeva, D. A., Vladimirovna, G. M., Chernyshova, E. V., Krutskikh, E. P., Novikova, A. G., & Popov, V. N. (2021) · Pharmaceuticals · doi:10.3390/ph14070607 · Cited by 73 · see citing works

Neuromicrobiology: How Microbes Influence the Brain

de la Fuente‐Núñez, C., Meneguetti, B. T., Franco, O. L., & Lu, T. K. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00373 · Cited by 68 · see citing works

Targeting the Microbiota in Pharmacology of Psychiatric Disorders

Pascale, A., Marchesi, N., Govoni, S., & Barbieri, A. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104856 · Cited by 67 · see citing works

Effects of Psychotropics on the Microbiome in Patients With Depression and Anxiety: Considerations in a Naturalistic Clinical Setting

Tomizawa, Y., Kurokawa, S., Ishii, D., Miyaho, K., Ishii, C., Sanada, K., Fukuda, S., Mimura, M., & Kishimoto, T. (2020) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa070 · Cited by 62 · see citing works

The Gut Microbiome in Schizophrenia and the Potential Benefits of Prebiotic and Probiotic Treatment

Liu, J. C. W., Gorbovskaya, I., Hahn, M., & Müller, D. J. (2021) · Nutrients · doi:10.3390/nu13041152 · Cited by 65 · see citing works

Strategies to counter antipsychotic-associated weight gain in patients with schizophrenia

Marteene, W., Winckel, K., Hollingworth, S., Kisely, S. R., Gallagher, E., Hahn, M., Ebdrup, B. H., Firth, J., & Siskind, D. J. (2019) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2019.1674809 · Cited by 62 · see citing works

Metabolic disturbances associated with antipsychotic drug treatment in patients with schizophrenia: State-of-the-art and future perspectives

Chang, S.-C., Goh, K. K., & Lu, M. (2021) · World Journal of Psychiatry · doi:10.5498/wjp.v11.i10.696 · Cited by 67 · see citing works

The scent of symbiosis: gut bacteria affect social interactions in leafcutting ants

Teseo, S., van Zweden, J. S., Pontieri, L., Kooij, P. W., Sørensen, S. J., Wenseleers, T., Poulsen, M., Boomsma, J. J., & Sapountzis, P. (2018) · Animal Behaviour · doi:10.1016/j.anbehav.2018.12.017 · Cited by 58 · see citing works

Roles of inflammation in intrinsic pathophysiology and antipsychotic drug-induced metabolic disturbances of schizophrenia

Prestwood, T. R., Asgariroozbehani, R., Wu, S., Agarwal, S. M., Logan, R. W., Ballon, J. S., Hahn, M., & Freyberg, Z. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.113101 · Cited by 58 · see citing works

The Microbiome–Gut–Behavior Axis: Crosstalk Between the Gut Microbiome and Oligodendrocytes Modulates Behavioral Responses

Ntranos, A., & Casaccia, P. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0597-9 · Cited by 52 · see citing works

Gut Biofactory—Neurocompetent Metabolites within the Gastrointestinal Tract. A Scoping Review

Skonieczna‐Żydecka, K., Jakubczyk, K., Maciejewska, D., Janda, K., Kaźmierczak-Siedlecka, K., Kaczmarczyk, M., Łoniewski, I., & Marlicz, W. M. (2020) · Nutrients · doi:10.3390/nu12113369 · Cited by 50 · see citing works

Modification of the gut microbiome to combat neurodegeneration

Sasmita, A. O. (2019) · Reviews in the Neurosciences · doi:10.1515/revneuro-2019-0005 · Cited by 46 · see citing works

Gut microbiome in schizophrenia and antipsychotic-induced metabolic alterations: a scoping review

Singh, R., Stogios, N., Smith, E., Lee, J., Maksyutynska, K., Au, E., Wright, D. C., Palma, G. D., Graff‐Guerrero, A., Gerretsen, P., et al. (2022) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253221096525 · Cited by 43 · see citing works

The Many Faces of Microbiota-Gut-Brain Axis in Autism Spectrum Disorder

Gonçalves, C. L., Doifode, T., Rezende, V. L., Costa, M. A., Rhoads, J. M., & Soutullo, C. A. (2024) · Life Sciences · doi:10.1016/j.lfs.2023.122357 · Cited by 42 · see citing works

Microbes and the Mind: How Bacteria Shape Affect, Neurological Processes, Cognition, Social Relationships, Development, and Pathology

Smith, L. K., & Wissel, E. F. (2019) · Perspectives on Psychological Science · doi:10.1177/1745691618809379 · Cited by 42 · see citing works

Association Between Abundance of Haemophilus in the Gut Microbiota and Negative Symptoms of Schizophrenia

Zhu, C., Zheng, M., Ali, U., Xia, Q., Wang, Z., Chenlong, Yao, L., Chen, Y., Yan, J., Wang, K., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.685910 · Cited by 41 · see citing works

Host genetics influences the relationship between the gut microbiome and psychiatric disorders

Martins‐Silva, T., Salatino‐Oliveira, A., Genro, J. P., Meyer, F. D. T., Li, Y., Rohde, L. A., Hutz, M. H., & Tovo‐Rodrigues, L. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110153 · Cited by 40 · see citing works

Microbiome Profiling Reveals Gut Dysbiosis in the Metabotropic Glutamate Receptor 5 Knockout Mouse Model of Schizophrenia

Gubert, C., Kong, G., Uzungil, V., Zeleznikow-Johnston, A., Burrows, E. L., Renoir, T., & Hannan, A. J. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.582320 · Cited by 38 · see citing works

Implications of Dietary Intake and Eating Behaviors for People with Serious Mental Illness: A Qualitative Study

Mueller‐Stierlin, A. S., Cornet, S., Peisser, A., Jaeckle, S., Lehle, J., Mörkl, S., & Teasdale, S. B. (2022) · Nutrients · doi:10.3390/nu14132616 · Cited by 34 · see citing works

Severe weight gain as an adverse drug reaction of psychotropics: Data from the AMSP project between 2001 and 2016

Schneider, M., Pauwels, P., Toto, S., Bleich, S., Grohmann, R., Heinze, M., & Greiner, T. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.05.001 · Cited by 31 · see citing works

Mechanism and treatments of antipsychotic-induced weight gain

Ye, W., Xing, J., Yu, Z., Hu, X., & Yan, Z. (2023) · International Journal of Obesity · doi:10.1038/s41366-023-01291-8 · Cited by 30 · see citing works

Alterations in the Nervous System and Gut Microbiota after β-Hemolytic Streptococcus Group A Infection—Characteristics and Diagnostic Criteria of PANDAS Recognition

Baj, J., Sitarz, R., Forma, A., Wróblewska, K., & Karakuła‐Juchnowicz, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041476 · Cited by 31 · see citing works

Comparison of gut microbiome profile in patients with schizophrenia and healthy controls - A plausible non-invasive biomarker?

Gokulakrishnan, K., Nikhil, J., Viswanath, B., Thirumoorthy, C., Narasimhan, S., Devarajan, B., Joseph, E., David, A. K. D., Sharma, S., Vasudevan, K., et al. (2023) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2023.05.021 · Cited by 25 · see citing works

Potential diagnostic biomarkers for schizophrenia

Yue, W., Huang, H., & Duan, J. (2022) · Medical Review · doi:10.1515/mr-2022-0009 · Cited by 24 · see citing works

In silico Identification of Metagenomic Signature Describing Neurometabolic Potential of Normal Human Gut Microbiota

Kovtun, A. S., Averina, O. V., Zakharevich, N. V., Kasianov, A. S., & Даниленко, В. Н. (2018) · Russian Journal of Genetics · doi:10.1134/s1022795418090089 · Cited by 23 · see citing works

Th17 and MAIT cell mediated inflammation in antipsychotic free schizophrenia patients

Varun, C. N., Venkataswamy, M. M., Ravikumar, R., Nagaraju, R., Debnath, M., Varambally, S. S., Venkatasubramanian, G., & Ravi, V. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.08.013 · Cited by 20 · see citing works

Sex-related patterns of the gut-microbiota-brain axis in the neuropsychiatric conditions

Manosso, L. M., Lin, J. H. X., Carlessi, A. S., Recco, K. C. C., Quevedo, J., Gonçalves, C. L., & Réus, G. Z. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.04.001 · Cited by 23 · see citing works

The regulatory effects of second-generation antipsychotics on lipid metabolism: potential mechanisms mediated by the gut microbiota and therapeutic implications

Chen, H., Cao, T., Zhang, B., & Cai, H. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1097284 · Cited by 18 · see citing works

A Potential Interface between the Kynurenine Pathway and Autonomic Imbalance in Schizophrenia

Büki, A., Kékesi, G., Horváth, G., & Vécsei, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810016 · Cited by 17 · see citing works

Profiling gut microbiota signatures associated with the deficit subtype of schizophrenia: Findings from a case-control study

Kowalski, K., Żebrowska-Różańska, P., Karpiński, P., Kujawa, D., Łaczmański, Ł., Samochowiec, J., Chęć, M., Piotrowski, P., & Misiak, B. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110834 · Cited by 16 · see citing works

What does immunology have to do with brain development and neuropsychiatric disorders?

Leckman, J. F., de Alvarenga, P. G., Salto, A. B. R., & Johnson, I. N. S. (2019) · Revista de Medicina · doi:10.11606/issn.1679-9836.v98i4p241-253 · Cited by 15 · see citing works

Caffeine consumption and schizophrenia: A highlight on adenosine receptor–independent mechanisms

Huang, L., & Sperlágh, B. (2021) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2021.09.003 · Cited by 16 · see citing works

Schizophrenia and gut-flora related epigenetic factors

Zhuo, C., Yao, Y., Xu, Y. J., Liu, C., Chen, M., Ji, F., Li, J., Tian, H., Jiang, D., Lin, C., et al. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.11.005 · Cited by 15 · see citing works

Microbiota changes associated with ADNP deficiencies: rapid indicators for NAP (CP201) treatment of the ADNP syndrome and beyond

Kapitansky, O., Giladi, E., Jaljuli, I., Bereswill, S., Heimesaat, M. M., & Gozes, I. (2020) · Journal of Neural Transmission · doi:10.1007/s00702-020-02155-5 · Cited by 15 · see citing works

Are probiotics effective in reducing the metabolic side effects of psychiatric medication? A scoping review of evidence from clinical studies

Mötteli, S., Vetter, S., Colla, M., & Hotzy, F. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02735-z · Cited by 14 · see citing works

Nutrition interventions in populations with mental health conditions: a scoping review

Cherak, S. J., Fiest, K. M., VanderSluis, L., Basualdo‐Hammond, C., Lorenzetti, D., Buhler, S., Stadnyk, J., Driedger, L., Hards, L., Gramlich, L. M., et al. (2020) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2019-0683 · Cited by 10 · see citing works

The influence of antibiotic treatment on the behavior and gut microbiome of adult rats neonatally insulted with lipopolysaccharide

Tejkalová, H., Jakob, L., Kvasnová, S., Klaschka, J., Sechovcová, H., Mrázek, J., Páleníček, T., & Fliegerova, K. O. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e15417 · Cited by 9 · see citing works

Gut microbes: Therapeutic Target for neuropsychiatric disorders

Mallick, K., Khodve, G., Ruwatia, R., & Banerjee, S. (2025) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2025.02.031 · Cited by 9 · see citing works

Plant- and Nutraceutical-based Approach for the Management of Diabetes and its Neurological Complications: A Narrative Review

Öztürk, Y., & Öztürk, N. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666191014165633 · Cited by 8 · see citing works

Human-fecal microbiota transplantation in relation to gut microbiome signatures in animal models for schizophrenia: A scoping review

Singh, R., Panganiban, K. J., Au, E., Ravikumar, R., Pereira, S., Prévot, T. D., Müller, D. J., Remington, G. J., Agarwal, S. M., Verdu, E. F., et al. (2024) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2024.104285 · Cited by 7 · see citing works

Mood Stabilizers: Side Effects, Contraindications, and Interactions

Himmerich, H., & Hamilton, A. M. (2020) · Springer eBooks · doi:10.1007/978-3-319-56015-1_40-1 · Cited by 7 · see citing works

Effect of Supplementation with Probiotics in Patients with Schizophrenia: Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials

Li, L., Du, F., Liu, X., Song, M., Grosso, G., Battino, M., Boesch, C., Li, H., & Liu, X. (2025) · Foods · doi:10.3390/foods14101773 · Cited by 6 · see citing works

Enriched developmental biology molecular pathways impact on antipsychotics-induced weight gain

Corfitsen, H. T., & Drago, A. (2019) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000390 · Cited by 6 · see citing works

Current and Novel Approaches to Mitigate Cardiometabolic Adverse Effects of Second-Generation Antipsychotics

Skonieczna‐Żydecka, K., Łoniewski, I., Stachowska, E., Marlicz, W. M., & Correll, C. U. (2020) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa026 · Cited by 6 · see citing works

Memory Reflections of the Microbiota-Gut and Oligodendrocyte Axis

Ray, S. K., & Mukherjee, S. (2023) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273256132230921103333 · Cited by 6 · see citing works

Modulating drug response through the gut microbiome: pathways to precision therapy

Kumar, N., Das, J., Vanangamudi, M., Mojgani, N., Islam, A., Sridhar, S. B., Sharma, H., Kumar, S., Panigrahy, U. P., Mantry, S., et al. (2026) · Archives of Microbiology · doi:10.1007/s00203-025-04688-3 · Cited by 4 · see citing works

Gut microbiota and autism

Wu, X., Shan, L., Wang, T., & Jin, F. (2018) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/n972017-01186 · Cited by 2 · see citing works

[Variations in fecal microbiota of first episode schizophrenia associated with clinical assessment and serum metabolomics].

Wang, X. P., Zhang, Y. Y., Lu, T.-L., Lu, Z., Kang, Z., Sun, Y., & Yue, W. (2022) · PubMed Central · doi:10.19723/j.issn.1671-167x.2022.05.014 · Cited by 3 · see citing works

Mood Stabilizers: Side Effects, Contraindications, and Interactions

Himmerich, H., & Hamilton, A. M. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_40 · Cited by 3 · see citing works

O uso probiótico no transtorno do espectro autista e na esquizofrenia: revisão narrativa da literatura

Gonçalves, C. M. R., Macedo, H. S., Fernandes, L. N. M., Araújo, I. D. S., de Araújo, R. P. C., & de Carvalho, J. F. (2020) · Revista de Ciências Médicas e Biológicas · doi:10.9771/cmbio.v19i4.37931 · Cited by 3 · see citing works

Gut Microbiome in Stress-related Disorders: The New Approaches to Neuroinflamation syndrome

Халтурина, Е. О., Klyueva, L. A., Boshiyan, R. E., Zembatov, G. M., & Alimova, A. M. (2022) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-196-12-74-82 · Cited by 2 · see citing works

The role of environmental factors in the etiology of schizophrenia

Brzuszkiewicz, K., Rudziński, G., Łozowski, B., Raczkiewicz, P., Kusak, N., & Soroka, E. (2023) · Journal of Education Health and Sport · doi:10.12775/jehs.2023.23.01.006 · Cited by 3 · see citing works

Gut Microbiota and Aging: A Broad Perspective

Pitchumoni, C. S., Mishra, S. P., & Yadav, H. (2020) · Springer eBooks · doi:10.1007/978-3-319-90761-1_59-1 · Cited by 2 · see citing works

Microbiome in psychiatry: where will we go?

Röttig, S., & Rujescu, D. (2018) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-017-0862-2 · Cited by 2 · see citing works

Therapeutic management of obesity induced by antipsychotic drugs

Merk, W., & Lew‐Starowicz, M. (2021) · Wiedza Medyczna · doi:10.36553/wm.70 · Cited by 1 · see citing works

Fecal Microbiota Transplantation for Alzheimer’s Disease: a Review of Current Evidence and Future Perspectives

Zou, Z., Yin, Y., Liao, B., Zhou, L., Su, M., & Li, X. (2025) · Current Clinical Microbiology Reports · doi:10.1007/s40588-025-00244-1 · Cited by 1 · see citing works

Suicidality as a potential risk and therapeutic target during widespread GLP-1 receptor agonists use: implications of inflammation

Borovčanin, M., & Petrović, I. (2026) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2026.1869086 · Cited by 1 · see citing works

Psychotropic Drug-Induced Disordered Eating Behaviors

Marzola, E., Musso, M., & Daga, G. A. (2021) · Springer eBooks · doi:10.1007/978-3-030-81174-7_8 · Cited by 1 · see citing works

Neuropsychiatric and Neurological Diseases in Relation to the Microbiota-Gut-Brain Axis: From Research to Clinical Care

Gulrandhe, P., Acharya, S., Shukla, S., & Patel, M. (2023) · Cureus · doi:10.7759/cureus.44819 · Cited by 1 · see citing works

Time-Restricted Feeding May Be a New Intervention to Improve Metabolism of Schizophrenia Patients

马, 雪. (2021) · International Journal of Psychiatry and Neurology · doi:10.12677/ijpn.2021.102006 · Cited by 1 · see citing works

FI: The Fecobiome Initiative

Sapountzis, P., Teseo, S., Otani, S., Aarestrup, F. M., Forano, É., Suen, G., Tsiamis, G., Haley, B. J., Kessel, J. A. V., & Huws, S. (2021) · Foodborne Pathogens and Disease · doi:10.1089/fpd.2021.0082 · Cited by 1 · see citing works

Gut Microbiota and Aging: A Broad Perspective

Pitchumoni, C. S., Mishra, S. P., & Yadav, H. (2021) · Springer eBooks · doi:10.1007/978-3-030-30192-7_59 · Cited by 1 · see citing works

Some Noncommunicable Diseases of the Central Nervous System with a Possible Infectious Etiology (in Collaboration with V.A. Orlova, I.I. Mikhailova, A.A. Garbuzov, D.A. Khavkina, P.V. Chukhliaev, T.A. Ruzhentsova I. L. Naidenova, A. B. Danilov, A.V. Simonova, E.G. Filatova, I.A. Pavlovsky, O.V. Bystrova, A.M. Zatevalov, S.L. Bezrodny, T.Sh. Sadekov)

Zinserling, V. A. (2022) · Springer eBooks · doi:10.1007/978-3-030-96260-9_20 · Cited by 1 · see citing works

Schizophrenia and Related Psychoses

(2025) · Wiley eBooks · doi:10.1002/9781119870203.mpg001.pub2 · Cited by 1 · see citing works

Differences in monozygotic twins: the implications of diet and intestinal microbioma

Cardoso, C. L., Afonso, C. M., & Bandarra, N. M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820047-6.00017-5

Antibiotic-induced dysbiosis does not potentiate the effect of lipopolysaccharide insult in male Wistar ratsPreprint

Tejkalová, H., Jakob, L., Kvasnová, S., Klaschka, J., Sechovcová, H., Mrázek, J., Páleníček, T., & Fliegerova, K. O. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.29.522253

Gut-Brain Axis: Probiotics as Psychobiotics

Singh, B., Mal, G., Kalra, R. S., & Marotta, F. (2024) · Springer eBooks · doi:10.1007/978-3-031-65459-6_16

Les bactéries comme actrices du microbiote intestinal entre inflammation, métabolisme des acides biliaires et interaction avec les bactériophages

Chaffringeon, L. (2022) · doi:10.70675/5333e3cdz0991z4f94z82faz68b44fe0a84b

Gut microbiota: An intermediary between metabolic syndrome and cognitive deficits in schizophrenia

Zeng, C., Yang, P., Cao, T., Gu, Y., Li, N., Zhang, B., Xu, P., Liu, Y., Luo, Z., & Cai, H. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110097 · Cited by 49 · see citing works

Gut Microbiota and Antipsychotics Induced Metabolic Alteration

Kan, D.-Y., Li, S., Liu, C., & Wu, R. (2019) · Global Clinical and Translational Research · doi:10.36316/gcatr.01.0020 · Cited by 4 · see citing works

Effect of Selected Antipsychotics on the Gut Microbiome and Their Metabolism in the Intestines

Pelikánová, K. (2026) · Digital Repository (National Repository of Grey Literature)

IUPHAR themed review: The gut microbiome in schizophrenia

Kamath, S., Sokolenko, E., Collins, K., Chan, N. S. L., Mills, N. T., Clark, S. R., Marques, F. Z., & Joyce, P. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107561 · Cited by 26 · see citing works

The Gut Microbiome in Schizophrenia and the Potential Benefits of Prebiotic and Probiotic Treatment

Liu, J. C. W., Gorbovskaya, I., Hahn, M., & Müller, D. J. (2021) · Nutrients · doi:10.3390/nu13041152 · Cited by 65 · see citing works